3146
G. Luchetti et al.
SPECIAL TOPIC
(3S,4R,5R,6R)-Tetrabenzyloxycyclohexene (7)27
Hydrolysis of Esters 10 and 11
To a solution of 5 (8 mg, 0.019 mmol) in DMF (0.6 mL) was added
NaH (4 mg of 60% dispersion in mineral oil, 0.1 mmol) at 0 °C. The
mixture was stirred for 15 min after which time BnBr (5 mL, 0.04
mmol) was added and the resulting solution was stirred overnight.
Et2O (3 mL) was added and the excess of NaH was quenched with
aq 1 M NH4Cl (2 mL). The organic layer was washed with H2O (2
× 2mL), dried (MgSO4), and evaporated. The residue was subjected
to preparative TLC (hexanes–EtOAc, 9:1) to give 9 mg (94%) of 7,
To a stirred solution of 10 or 11 (20 mg, 0.035 mmol) in THF (0.5
mL) was added aq 1 M LiOH (0.5 mL). The reaction mixture was
stirred for 3 h at rt. The solvent was evaporated and the residue chro-
matographed (hexanes–EtOAc, 9:1) to yield pure 5 (14.1 mg, 97%)
or 4 (13.8 mg, 95%).
Acknowledgment
1
whose H NMR spectrum was identical to that reported previous-
ly.27
A.K. would like to acknowledge the financial support from the US
National Institutes of Health (RR-16480 and CA-99957) under the
BRIN/INBRE and AREA programs. M.D. acknowledges the finan-
cial support from the National Institutes of Health (DK-44589 and
GM-84819). The content is solely the responsibility of the authors
and does not necessarily represent the official views of the National
Institutes of Health.
3,4,5,6-Tetra-O-benzyl-D-myo-inositol (8)19
To a solution of 6 (6 mg, 0.012 mmol) and NMO (2 mg, 0.017
mmol) in acetone–H2O (9:1, 0.6 mL) was added a catalytic amount
of OsO4. The mixture was stirred for 3 d at r.t. and treated with Et2O
(3 mL). The organic layer was washed with aq 10% Na2S2O3 (2
mL), H2O (2 mL), dried (MgSO4), and evaporated. The residue con-
sisted of 8, which was >98% pure by TLC and 1H NMR spectrosco-
References
1
py (5.8 mg, 89%). H NMR spectrum of 8 was identical to that
reported previously.19
(1) (a) Posternak, T. Chemistry of the Cyclitols – The Cyclitols;
Hermann: Paris, 1965. (b) Hudlicky, T.; Cebulak, M.
Cyclitols and Derivatives. A Handbook of Physical, Spectral
and Synthetic Data; VCH: Weinheim, 1993. (c) Ferrier, R.
J.; Middleton, S. Chem. Rev. 1993, 93, 2779. (d)Billington,
D. C. The Inositol Phosphates – Chemical Synthesis and
Biological Significance; VCH: Weinheim, 1993.
(e) Hudlicky, T.; Entwistle, D. A.; Pitzer, K. K.; Thorpe, A.
J. Chem. Rev. 1996, 96, 1195. (f) Gültekin, M. S.;Çelik, M.;
Balci, M. Curr. Org. Chem. 2004, 8, 1159.
1,2,3,4-Tetra-O-benzyl-L-chiro-inositol (9)18
To a solution of 7 (6 mg, 0.012 mmol) and NMO (2 mg, 0.017
mmol) in acetone–H2O (9:1, 0.6 mL) was added a catalytic amount
of OsO4. The mixture was stirred for 2 h at r.t. and treated with Et2O
(3 mL). The organic layer was washed with aq 10% Na2S2O3 (2
mL), H2O (2 mL), dried (MgSO4), and evaporated. The residue con-
1
sisted of 9, which was >98% pure by TLC and H NMR (5.9 mg,
93%). 1H NMR spectrum of 9 was identical to that reported previ-
ously.18
(2) Potter, B. V. L.; Lampe, D. Angew. Chem., Int. Ed. Engl.
1995, 34, 1933.
(3) See: Chakraborty, N.; d’Alarcao, M. Bioorg. Med. Chem.
2005, 13, 6732; and references cited therein.
(4) Billington, D. C.; Perron-Sierra, F.; Beaubras, S.; Duhault,
J.; Espinal, J.; Challal, S. Bioorg. Med. Chem. Lett. 1994, 4,
2307.
(5) (a) Balci, M.; Sütbeyaz, Y.; Seçen, H. Tetrahedron 1990, 46,
3715. (b) Balci, M. Pure Appl. Chem. 1997, 69, 97; and
references cited therein.
Mitsunobu Inversion of Conduritols 4 and 5
To a stirred solution of 4 or 5 (30 mg, 0.072 mmol) in Et2O (1.25
mL) was added PPh3 (19 mg, 0.072 mmol) and 4-nitrobenzoic acid
(12 mg, 0.072 mmol) at r.t. After the material had dissolved, DIAD
(17.7 mL, 0.074 mmol) was added to the mixture. After stirring for
17 h at r.t., the mixture was concentrated under reduced pressure
and the residue was chromatographed (hexanes–EtOAc, 9:1) to
yield pure 10 (37 mg, 89%) or 11 (39 mg, 94%).
(6) (a) Legler, G.; Herrchen, M. FEBS Lett. 1981, 135, 139.
(b) Atsumi, S.; Iinuma, H.; Nosaka, C.; Umezawa, K.
J. Antibiot. 1990, 43, 1579. (c) Atsumi, S.; Umezawa, K.;
Iinuma, H.; Naganawa, H.; Nakamura, H.; Iitaka, I.;
Takeuchi, T. J. Antibiot. 1990, 43, 49.
(7) Sureshan, K. M.; Shashidhar, M. S.; Praveen, T.; Das, T.
Chem. Rev. 2003, 103, 4477.
(8) Kiddle, J. J. Chem. Rev. 1995, 95, 2189.
(9) See, for example: Saito, S.; Shimazawa, R.; Shirai, R. Chem.
Pharm. Bull. 2004, 52, 727.
(10) See, for example: Dubreuil, D.; Cleophax, J.; de Almeida,
M. V.; Verre-Sebrié, C.; Liaigre, J.; Vass, G.; Géro, S. D.
Tetrahedron 1997, 53, 16747.
(11) See, for example: Chiara, J. L.; Martín-Lomas, M.
Tetrahedron Lett. 1994, 35, 2969.
(12) See, for example: Guidot, J. P.; Le Gall, T.; Mioskowski, C.
Tetrahedron Lett. 1994, 35, 6671.
(13) Kireev, A. S.; Breithaupt, A. T.; Collins, W.; Nadein, O. N.;
Kornienko, A. J. Org. Chem. 2005, 70, 742.
(14) For preliminary account of this work, see: Kornienko, A.;
d’Alarcao, M. Tetrahedron: Asymmetry 1999, 10, 827.
(15) For other examples of utilization of ring-closing metathesis
in cyclitol synthesis, see: (a) Verhelst, S. H. L.; Wennekes,
T.; van der Marel, G. A.; Overkleeft, H. S.; van Boeckel, C.
A. A.; van Boom, J. H. Tetrahedron 2004, 60, 2813.
(b) Andersen, T. L.; Skytte, D. M.; Madsen, R. Org. Biomol.
Chem. 2004, 2, 2951. (c) Heo, J. N.; Holson, E. B.; Roush,
(1R,4S,5R,6R)-4,5,6-Tris(benzyloxy)cyclohex-2-enyl 4-Nitro-
benzoate (10)
[a]D20 –114.3 (c 0.1, CHCl3).
1H NMR (CDCl3): d = 8.28 (d, J = 8.5 Hz, 2 H), 8.18 (d, J = 8.5, 2
H), 7.36–7.23 (m, 15 H), 6.04–5.87 (m, 3 H), 4.99–4.67 (m, 6 H),
4.16–4.04 (m, 2 H), 3.73 (dd, J = 3.0, 9.9 Hz, 1 H).
13C NMR (CDCl3): d = 164.3, 150.6, 138.6, 138.2, 138.0, 135.7,
134.2, 131.0, 128.8, 128.6, 128.4, 128.2, 128.0, 127.8, 123.6, 123.1,
79.8, 78.4, 77.9, 77.3, 75.3, 72.8, 68.3.
HRMS (ESI): m/z calcd for C34H31NO7 + Na (M + Na)+: 588.1998;
found: 588.1982.
(1S,4S,5R,6R)-4,5,6-Tris(benzyloxy)cyclohex-2-enyl 4-Nitro-
benzoate (11)
[a]D20 +156.8 (c 0.05, CHCl3).
1H NMR (CDCl3): d = 8.24 (d, J = 8.8 Hz, 2 H), 8.02 (d, J = 8.8 Hz,
2 H), 7.36–7.10 (m, 15 H), 5.83 (m, 2 H), 5.64 (d, J = 10.5 Hz, 1 H),
4.98–4.67 (m, 6 H), 4.30 (dd, J = 2.8, 4.7 Hz, 1 H), 3.93–3.85 (m, 2
H).
13C NMR (CDCl3): d = 164.1, 150.6, 138.5, 138.1, 135.3, 130.9,
130.0, 128.6, 128.5, 128.4, 128.1, 128.1, 127.9, 127.7, 125.4, 123.5,
83.8, 81.1, 79.8, 77.5, 75.8, 75.7, 72.7.
HRMS (ESI): m/z calcd for C34H31NO7 + Na (M + Na)+: 588.1998;
found: 588.1995.
Synthesis 2008, No. 19, 3142–3147 © Thieme Stuttgart · New York